Fenchyl Alcohol

Fenchyl Alcohol

SCHEMBL1245968

CC1(C)[C@@H]2CC[C@@](C)(C2)[C@@H]1O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.43
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TAS1R3 Q7RTX0 2/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
APP P05067 5/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
TAS1R2 Q8TE23 1/20 0.33
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenchyl Alcohol SCHEMBL29410040 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL58038 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL31196741 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL1868362 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL18316482 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL9643767 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL23754247 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL17746907 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL21155381 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19
Fenchyl Alcohol SCHEMBL20574452 1.00 GPR84 (0.43) GPR84CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119220269-A Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element and manufacturing method thereof 日产化学株式会社 2024-12-31 CN claimed
EP-4291669-A2 ENANTIOSELECTIVE HYDROLYSIS Technische Universität Graz (AT) 2023-12-20 EP claimed
WO-2022171652-A2 ENANTIOSELECTIVE HYDROLYSIS TECHNISCHE UNIVERSITÄT GRAZ (AT) 2022-08-18 WO claimed
EP-4043577-A1 ENANTIOSELECTIVE HYDROLYSIS Technische Universität Graz (AT) 2022-08-17 EP claimed
EP-3387099-B1 FOOD CONTACT SURFACE SANITIZING LIQUID CLOROX CO (US) 2021-07-21 EP claimed
US-20190209441-A1 GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR WELLA OPERATIONS US, LLC 2019-07-11 US claimed
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR WELLA OPERATIONS US, LLC 2019-06-27 US claimed
US-20190175476-A1 HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR WELLA OPERATIONS US, LLC 2019-06-13 US claimed
WO-2018053183-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR NOXELL CORPORATION (US) 2018-03-22 WO claimed
WO-2018053065-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR THE PROCTER & GAMBLE COMPANY (US) 2018-03-22 WO claimed
EP-3295925-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR Noxell Corporation (US) 2018-03-21 EP claimed
WO-2018048933-A1 HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR NOXELL CORPORATION (US) 2018-03-15 WO claimed
WO-2018048924-A1 GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR NOXELL CORPORATION (US) 2018-03-15 WO claimed
EP-3290085-A1 HAIR COLOURING OR BLEACHING COMPOSITION WITH REDUCED ODOUR Noxell Corporation (US) 2018-03-07 EP claimed
EP-3290086-A1 GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR Noxell Corporation (US) 2018-03-07 EP claimed
EP-1894603-B1 Encapsulation of bulky fragrance molecules TAKASAGO PERFUMERY CO LTD (JP) 2014-11-19 EP claimed
WO-1991002711-A2 7,7-DIMETHYLNORBORNANE DERIVATIVES THE COCA-COLA COMPANY (US) 1991-03-07 WO claimed
US-4195100-A Use of 2-oxabicyclooctane derivatives in augmenting or enhancing the flavor of a foodstuff INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1980-03-25 US claimed
EP-4210663-B1 LATE-STAGE PRODUCT DIFFERENTIATION PROCESS FOR PERSONAL CARE PRODUCTS PROCTER & GAMBLE (US) 2026-04-29 EP disclosed
US-4195100-A Use of 2-oxabicyclooctane derivatives in augmenting or enhancing the flavor of a foodstuff INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1980-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR MAL2, MSH6, OR51E2 GPR84 1723/4885CYP3A4 1285/4885CYP2D6 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.